Available now at MDLinx Gastroenterology: Ranked summaries of the most clinically-relevant GI literature refreshed every 24 hours, as well as MDLinx Gastroenterology exclusive content
Your Unread Messages in Gastroenterology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pediatric Gastroenterology Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Transition rates for adenomas to CRC
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
1 Chronic hepatitis B: a treatment update Seminars in Liver Disease, June 18, 2013 Clinical Article
2 Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection Journal of Hepatology, June 18, 2013 Clinical Article
3 Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones Diagnostic Microbiology and Infectious Disease, June 18, 2013 Clinical Article
4 Review of hepatitis B surveillance in China: Improving information to frame future directions in prevention and control Vaccine , June 18, 2013 Review Article
5 Low level of immunity against hepatitis A among Korean adolescents: Vaccination rate and related factors American Journal of Infection Control, June 18, 2013 Clinical Article
6 Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation Journal of Gastroenterology, June 18, 2013 Review Article
7 Antiviral therapy for chronic hepatitis B in pregnancy Seminars in Liver Disease, June 17, 2013 Clinical Article
8 Antibody-secreting cells with a phenotype of ki-67low, CD138high, CD31high, and CD38high secrete nonspecific IGM during primary hepatitis A virus infection The Journal of Immunology, June 17, 2013 Evidence Based Medicine
9 Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes Journal of Virology, June 17, 2013 Review Article
10 Protection against avian necrotic enteritis after immunisation with NetB genetic or formaldehyde toxoids Vaccine , June 17, 2013 Review Article
11 miR146a impairs the IFN-induced anti-HBV immune response by down-regulating STAT1 in hepatocytes Liver International, June 17, 2013 Review Article
12 Human La protein interaction with GCAC near the initiator AUG enhances hepatitis C virus RNA replication by promoting linkage between 5' and 3' untranslated regions Journal of Virology, June 17, 2013 Review Article
13 The role of small intestinal bacterial overgrowth in Parkinsons disease Movement Disorders, June 17, 2013 Review Article
14 Molecular mechanisms of HBV-associated hepatocarcinogenesis Seminars in Liver Disease, June 17, 2013 Review Article
15
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase
Journal of Virology, June 17, 2013
Review Article
Exclusive Author Commentary
16 Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan Full Text World Journal of Gastroenterology, June 17, 2013 Clinical Article
17 Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements Clinical Infectious Diseases, June 14, 2013 Clinical Article
18 New therapeutic targets and drugs for the treatment of chronic hepatitis B Seminars in Liver Disease, June 14, 2013 Clinical Article
19 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children Cochrane Reviews, June 14, 2013 Evidence Based Medicine
20 Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease Seminars in Liver Disease, June 14, 2013 Clinical Article
As published in the NEJM, researchers in the COLONPREV study (Spain) have reported that fecal immunochemical testing (FIT) is as effective as colonoscopy in the detection of colorectal cancer (CRC). The study population was 50-69 years of age and comprised of 26,703 subjects who underwent a one-time colonoscopy and 26,599 subjects who underwent FIT every 2 years. The primary outcome measure was CRC deaths at 10 years. Participation in screening was greater in the FIT group than the colonoscopy group (34.2% vs. 24.6%). Detection of CRC was similar between the two groups (0.1%). Advanced and non-advanced adenomas were detected more frequently in the colonoscopy group than the FIT group (1.9% vs. 0.9% [OR=2.3] and 4.2% vs. 0.4% [OR=9.8], respectively).
Read the article summaryBased on a meta-analysis involving 30 observational studies and 202,965 patients, proton pump inhibitor therapy has been shown to significantly increase the risk of infection with Clostridium difficile (OR = 2.15).
Read the article summaryIn a single institution study involving 424 patients with DM and CRC, those patients treated with metformin had a 30% improvement in OS compared with patients not treated with metformin. Specifically, the metformin-treated patients had a mean survival of 76.9 months compared to 56.9 months.
Read the article summary1 Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy, Canadian Journal of Gastroenterology, May 7, 2013
2 Prophylactic effect of antiretroviral therapy on hepatitis B virus infection Clinical Infectious Diseases, May 30, 2013
3 Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and meta-analysis Colorectal Disease, May 16, 2013 Evidence Based Medicine Review Article
4 A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease Journal of Gastroenterology, May 15, 2013
5 Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy? Saudi Journal of Gastroenterology, May 17, 2013 Free full text
6 Basidiobolomycosis: an emerging fungal infection of the gastrointestinal tract in adults American Journal of Infectious Diseases, May 14, 2013 Free full text
7 Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections Clinical Infectious Diseases, May 14, 2013
8 Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study The Lancet, May 15, 2013 Evidence Based Medicine
9 Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus-Coinfected Patients With Compensated Cirrhosis Clinical Infectious Diseases, May 3, 2013
10
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
Gut, May 22, 2013
Exclusive Author Commentary
11 Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials Clinical Therapeutics, March 5, 2013
12 Treatment of delta hepatitis Expert Review of Anti-infective Therapy, May 7, 2013
13 Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch Seminars in Pediatric Surgery, May 3, 2013
14 Mortality in Clostridium difficile infection: a prospective analysis of risk predictors European Journal of Gastroenterology & Hepatology, May 13, 2013
15 Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era Clinical Transplantation, May 15, 2013
16 Predictors of the change in bilirubin levels over twelve weeks of treatment with atazanavir AIDS Research and Therapy, May 17, 2013 Free full text
17 A Screening Trial of Helicobacter pylori-Specific Antigen Tests in Saliva to Identify an Oral Infection Digestion, May 7, 2013
18 Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection Journal of Viral Hepatitis, May 8, 2013
19 Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication International Journal of Hematology, May 2, 2013 Review Article
20 Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population Journal of Crohn's and Colitis, May 2, 2013
Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gut more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close